Erenumab Autoinjector Well Received by Patients, Study Finds

July 28, 2020


When it comes to ease of use, ability to self-inject, and confidence in using an erenumab-prefilled disposable autoinjector, individuals with migraine consistently endorsed the preventive treatment, according to study results published in Patient Preference and Adherence.

Data Highlight Long-Term Efficacy of Erenumab for Episodic Migraine

July 28, 2020


In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to evaluate the efficacy and safety of erenumab in migraine prevention (STRIVE), published in Neurology.

Review Explores Association Between Chronic Migraine, Suicide Ideation

July 23, 2020


Current existing research highlights the important association between the increased risk of suicidal behaviors among chronic migraineurs with and without aura, in both the clinical and general population worldwide, according to a systematic review published in Frontiers in Neurology.

Meta-Analysis Outlines Interrelationship of Migraine, Blood Pressure

July 22, 2020


Positive genetic correlations of migraine with diastolic blood pressure (BP) and systolic BP exist, supporting the notions that diastolic BP plays a critical role in migraine susceptibility and BP and migraine share underlying biological mechanisms, according to a study published in Nature Communications.

Can Adulthood Attachment Mediate the Effects of Childhood Trauma on Migraine?

July 16, 2020


The direct effect of childhood trauma on migraine is outweighed by the mediation effect of adulthood attachment, according to a study published in the International Journal of Environmental Research and Public Health.

Can Machine Learning Predict Medication Overuse in Migraineurs?

July 15, 2020


A combination of machine learning and random optimization may aid in predicting medication overuse in migraineurs, if clinical/biochemical features, drug exposure, and lifestyle are taken into consideration, according to a study published in Computational and Structural Biotechnology Journal.

How Does Quarantine Impact Migraineurs?

July 07, 2020


A survey conducted among migraineurs in Genova, Italy, found that during the coronavirus disease 2019 (COVID-19) quarantine, patients experienced fewer migraine attacks and less pain but exhibited moderate levels of depression correlated to migraine burden.

Experts Push for Limiting Co-pays, Increasing Migraine Medication Access During Pandemic

July 05, 2020


A recent article in the Journal of Head and Face Pain outlines strategies for migraine treatment without face-to-face visits, and describes ways health insurance companies can remove barriers to migraine care during the coronavirus disease 2019 (COVID-19) pandemic.

AAN, AHS Release Updated Guidance on Short-Term Migraine Treatment in Children, Adolescents

July 01, 2020


The American Academy of Neurology (AAN) and the American Headache Society (AHS) released updated guidance on short-term treatment of migraine in children and adolescents.

How Do Migraine Symptoms, Triggers Differ Based on Sex?

June 29, 2020


Female migraineurs tend to exhibit longer attack duration and greater frequency of nausea, vomiting, osmophobia, and vertigo/dizziness, compared with male migraineurs, according to a community-based study.